Nomura Holdings
TBRA

Nomura Holdings’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Nomura Holdings’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,222
Closed -$15K – 2542
2014
Q4 		$15K Buy
+1,222
New +$10.5K ﹤0.01% 2226

Other funds holding TBRA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's TBRA Position: Q1 2015 in Review

Nomura Holdings sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q1 2015, closing a stake of 1,222 shares — an estimated $15K sold.

Nomura Holdings first reported a position in TBRA in Q4 2014 and held it in 1 quarter. The position peaked at $15K in Q4 2014. 38 funds tracked by Wall St. Rank hold TBRA as of Q1 2015.

  • Nomura Holdings reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Nomura Holdings sold 1,222 Tobira Therapeutics, Inc. Common Stock shares in Q1 2015, an estimated $15K.
  • Nomura Holdings first reported a position in Tobira Therapeutics, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • Nomura Holdings's Tobira Therapeutics, Inc. Common Stock position peaked at $15K in Q4 2014.
  • 38 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q1 2015.

Based on Nomura Holdings's 13F filing for Q1 2015, filed 15 May 2015.